Indolocarbazoles and the use thereof
    10.
    发明授权
    Indolocarbazoles and the use thereof 失效
    Indolocarbazoles及其用途

    公开(公告)号:US5043335A

    公开(公告)日:1991-08-27

    申请号:US557299

    申请日:1990-07-23

    CPC分类号: C07D498/22

    摘要: The present invention provides 9,10,11,12-tetrahydro-9,12-epoxy-1H-diindolo [1,2,3-fg: 3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-1,3(2H)-dione and 9,10,11,12-tetrahydro-2-(tetrahydro-5-methoxy-2-furanyl) -9,12-epoxy-1H-diindolo[1,2,3-fg: 3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-1,3(2H)-dione process for the preparation thereof, pharmaceutical compositions containing the compounds, and use of the compounds in heart and blood vessel diseases such as thromboses, arterioscleroses, hypertension and inflammatory diseases, allergies, cancer and certain degenerative damage of the central nervous system, as well as diseases of the immune system.

    摘要翻译: 本发明提供9,10,11,12-四氢-9,12-环氧-1H-二吲哚并[1,2,3-fg:3',2',1'-k]吡咯并[3,4-i ] [1,6]苯并二氮辛啶-1,3(2H) - 二酮和9,10,11,12-四氢-2-(四氢-5-甲氧基-2-呋喃基)-9,12-环氧基-1H-二吲哚 [1,2,3-fg:3',2',1'-kl]吡咯并[3,4-i] [1,6]苯并二氮杂辛基-1,3(2H) - 二酮制备方法 含有化合物的组合物,以及化合物在心血管疾病如血栓形成,动脉硬化症,高血压和炎性疾病,过敏症,癌症和中枢神经系统的某些退行性损伤以及免疫系统疾病中的用途。